# Integrated Approaches for Identifying Molecular Targets in Liver Disease

> **NCT03915002** · — · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 155 (actual)

## Conditions studied

- Alcoholic Liver Disease
- Non-Alcoholic Fatty Liver Disease
- Steatohepatitis, Nonalcoholic
- Steatohepatitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03915002
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-13
- **Primary completion:** 2023-04-12
- **Final completion:** 2023-04-12
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03915002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03915002, "Integrated Approaches for Identifying Molecular Targets in Liver Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03915002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*